Thursday, May 15, 2014
Publication and contact
Assays & screens
Signature of 24 genes to
predict prostate cancer recurrence
identified a 24-gene panel that could help predict disease recurrence in
patients with prostate cancer. In 106 prostate tumor samples, RNA sequencing
led to the identification of a 24-gene signature that differentiated patients
at high and low risk of disease recurrence when combined with assessment of
clinical variables. In a validation dataset from 140 patients with prostate
cancer, assessing clinical variables together with the 24-gene panel resulted
in increased predictive capability of disease recurrence compared with
assessing clinical variables alone or in combination with a gene signature
from a panel of 31 cell-cycle progression genes. Next steps include
validating the biomarkers in a larger patient cohort.
Published online May 15, 2014
Patent application filed;
available for licensing
Long, Q. et al. Cancer
Res.; published online April 8, 2014;
Contact: Carlos S. Moreno, Emory University,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]